epocrates logo
epocrates logo
epocrates logo
  • 0

Diseases

Evaluation of metabolic acidosis

OVERVIEW

  • Summary
  • Urgent Considerations
  • Etiology

DIAGNOSIS

  • Differential Diagnosis
  • Diagnostic Approach

IMAGES

  • Library

REFERENCES

  • Citations
  • Credits

Summary

AAFont SizeShareMore Information
Metabolic acidosis is indicated by a decrease in the plasma bicarbonate level and/or a marked increase in the serum anion gap (AG). Arterial pH <7.35 defines acidosis. The presence of metabolic acidosis is a clue to the possible existence of several underlying medical conditions.
Metabolic acidosis may occur due to:
  • Addition of strong acid that is buffered by and consumes bicarbonate ion

  • Loss of bicarbonate ion from the body fluids, usually through the GI tract or kidneys

  • Rapid addition to the extracellular fluid of a nonbicarbonate solution.

Calculating serum AG helps to differentiate the cause. Serum AG is calculated by subtracting the sum of major measured anions, chloride (Cl¯) and bicarbonate (HCO₃¯), from the major measured cation, sodium (Na⁺).
  • AG = Na⁺ - (Cl¯ + HCO₃¯)

Normal serum AG is due to the difference between unmeasured anions such as sulfate (SO₄²¯), phosphate (PO₄¯), albumin, and organic anions, and unmeasured cations such as potassium (K⁺), magnesium (Mg⁺), and calcium (Ca²⁺). Plasma proteins also play a role in maintaining normal serum AG.[1]
Acute metabolic acidosis, lasting minutes to several days, is relatively common among critically ill patients with reported incidence varying from 6% for more severe acidosis (plasma pH <7.20) to up to 64%.[1] [2] [3] [4]​ In one multicenter, retrospective study, 14% of intensive care unit (ICU) patients had metabolic acidosis (median incidence at a study ICU 172.5 patients per year), suggesting identification and management is a relevant issue in the critically ill.[5]
Chronic metabolic acidosis, lasting weeks to years, may occur in up to 20% of patients with chronic kidney disease.[6]​ Its frequency is likely to increase with a rise in chronic kidney disease among older people.[7]
content by BMJ Group
Last updated

Citations

    Key Articles

    • Jung B, Martinez M, Claessens YE, et al. Diagnosis and management of metabolic acidosis: guidelines from a French expert panel. Ann Intensive Care. 2019 Aug 15;9(1):92.[Abstract][Full Text]

    • Royal College of Pathologists of Australasia. Acidosis. Jan 2024 [internet publication].[Full Text]

    Referenced Articles

    • 1. Dubin A, Menises MM, Masevicius FD, et al. Comparison of three different methods of evaluation of metabolic acid-base disorders. Crit Care Med. 2007 May;35(5):1264-70. [Abstract]

    • 2. Jung B, Rimmele T, Le Goff C, et al. Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care. 2011;15(5):R238.[Abstract][Full Text]

    • 3. Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol. 2012 Oct;8(10):589-601.[Abstract][Full Text]

    • 4. Gunnerson KJ, Saul M, He S, et al. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care. 2006 Feb;10(1):R22.[Abstract][Full Text]

    • 5. Fujii T, Udy AA, Nichol A, et al. Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU: an international observational study. Crit Care. 2021 Feb 2;25(1):45.[Abstract][Full Text]

    • 6. Adamczak M, Surma S. Metabolic acidosis in patients with CKD: epidemiology, pathogenesis, and treatment. Kidney Dis (Basel). 2021 Nov;7(6):452-67.[Abstract][Full Text]

    • 7. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010 May;6(5):274-85.[Abstract]

    • 8. Winter SD, Pearson JR, Gabow PA, et al. The fall of the serum anion gap. Arch Intern Med. 1990 Feb;150(2):311-3.[Abstract]

    • 9. Matyukhin I, Patschan S, Ritter O, et al. Etiology and management of acute metabolic acidosis: An update. Kidney Blood Press Res. 2020;45(4):523-531.[Abstract][Full Text]

    • 10. Fenves AZ, Emmett M. Approach to patients with high anion gap metabolic acidosis: Core curriculum 2021. Am J Kidney Dis. 2021 Oct;78(4):590-600.[Abstract][Full Text]

    • 11. Jung B, Martinez M, Claessens YE, et al. Diagnosis and management of metabolic acidosis: guidelines from a French expert panel. Ann Intensive Care. 2019 Aug 15;9(1):92.[Abstract][Full Text]

    • 12. Ertmann A, Thompson RE, Hoo ZH, et al. Severe lactic acidosis associated with oral linezolid. Drug Ther Bull. 2025 Dec 3;63(12):188-91.[Abstract]

    • 13. Fujii T, Udy A, Licari E, et al. Sodium bicarbonate therapy for critically ill patients with metabolic acidosis: a scoping and a systematic review. J Crit Care. 2019 Jun;51:184-91.[Abstract][Full Text]

    • 14. Jaber S, Paugam C, Futier E, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet. 2018 Jul 7;392(10141):31-40.[Abstract][Full Text]

    • 15. Jung B, Jabaudon M, De Jong A, et al. Sodium bicarbonate for severe metabolic acidemia and acute kidney injury: the BICARICU-2 randomized clinical trial. JAMA. 2025 Dec 9;334(22):2000-10.[Abstract][Full Text]

    • 16. ISRCTN: ​the UK's Clinical Study Registry. Multicentre evaluation of sodium bicarbonate in acute kidney injury in critical care (MOSAICC). Oct 2025 [internet publication].​[Full Text]

    • 17. Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014 Jan 8;371(2):1434-45.[Abstract]

    • 18. Seifter JL. Integration of acid-base and electrolyte disorders. N Engl J Med. 2014 Jan 22;371(4):1821-31.[Abstract]

    • 19. Royal College of Pathologists of Australasia. Acidosis. Jan 2024 [internet publication].[Full Text]

    • 20. Fencl V, Miller TB, Pappenheimer JR. Studies on respiratory response to disturbances of acid-base balance, with deductions concerning the ionic composition of cerebral interstitial fluid. Am J Physiol. 1966 Mar;210(3):459-66.[Abstract]

    • 21. Elkinton JR. Clinical disorders of acid-base regulation: A survey of seventeen years diagnostic experience. Med Clin North Am. 1966 Sep;50(5):1325-50.[Abstract]

    • 22. Gabow PA, Kaehny WD, Fennessey PV, et al. Diagnostic importance of an increased serum anion gap. N Engl J Med. 1980 Oct 9;303(15):854-58.[Abstract]

    • 23. Batlle DC, Hizon M, Cohen E, et al. The use of urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med. 1988 Mar 10;318(10):594-9.[Abstract]

    • 24. Rehman A, Setter SM, Vue MH. Drug-induced glucose alterations part 2: Drug-induced hyperglycemia. Diabetes Spect. 2011 Nov;24(4)234-8.[Full Text]

    • 25. U.S. Food and Drug Administration. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections: FDA drug safety communication​. Mar 2022 [internet publication].[Full Text]

    • 26. Medicines and Healthcare products Regulatory Agency. SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis. Apr 2016 [internet publication].[Full Text]

    • 27. Sitina M, Lukes M, Sramek V. Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis. BMC Endocr Disord. 2023 Apr 14;23(1):81.[Abstract][Full Text]

    • 28. FDA. Drug Safety Update: SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis. May 2015 [internet publication].[Full Text]

    • 29. Medicines and Healthcare products Regulatory Agency. SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis. April 2016 [internet publication].[Full Text]

    • 30. Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024 Aug 1;47(8):1257-75.[Abstract][Full Text]

    • 31. Shapiro JI. Pathogenesis of cardiac dysfunction during metabolic acidosis: therapeutic implications. Kidney Int. 1997 Oct;61:S47-51.[Abstract]

    • 32. McGuire LC, Cruickshank AM, Munro PT. Alcoholic ketoacidosis. Emerg Med J. 2006 Jun;23(6):417-20.[Abstract][Full Text]

Have feedback?
Tell us about your experience
Scroll to Top
epocrates logo

Sign in to access our clinical decision support tools

Sign inCreate Account
Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information